Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Infectious diseases

Disease Area Infectious diseases

An Unlikely Source of Inspiration

| Olivia Gaskill | 2 min read

Why is the BCG vaccine an all-rounder for protecting against multiple bacterial infections?

Disease Area Infectious diseases

Recharging After Long COVID

| Geoffrey Potjewyd | 2 min read

Can we repair the visual and cognitive damage caused by long COVID?

Disease Area Infectious diseases

A Step Closer to a Universal Flu Vaccine

| Maryam Mahdi

Can newly discovered antibodies help us do away with annual flu vaccinations?

Disease Area Infectious diseases

Archived Antivirals

Longstanding treatments for tapeworm could take on COVID-19

Tools & Techniques Imaging

Catching Viral RNA Translation in the Act

Bicistronic biosensor illuminates when a virus hijacks its host

Tools & Techniques Analytical science

The Mass Spec COVID Check

| Maarten Dhaenens

MS could be key to improving COVID-19 testing accuracy and capacity

Research Field Immunology

Weathering the Cytokine Storm

| Charlotte Barker

THC halts the immune cascade that causes acute respiratory distress syndrome in mice

Research Field Diagnostics & prognostics

Pandemic Proteomics

An MS-based proteomics platform is painting a picture of variable patient responses to COVID-19

Disease Area Infectious diseases

Rage Against the Dying of the Light

Sitting Down With… Jose Pulido, Larry A. Donoso Endowed Chair, Wills Eye

Research Field Drug discovery

Small, But Mighty

| Brent R Stockwell

Small-molecule inhibition of the SARS-CoV-2 viral protease may represent a promising route for therapy


Sister Publications

You might be interested in our Sister Publications:

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register